220 Controlled substances; definitions

First: do NOT speak to any federal agent without counsel. Period. Not the DEA, not the OIG, not the FBI. You have the right to counsel and exercising that right cannot be held against you.

Second: get a consultation NOW, before anything formal happens. Pre-investigation counsel is dramatically more effective (and less expensive) than post-indictment defense. Many healthcare fraud defense attorneys offer free initial consultations.

Third: do NOT alter any records. Do NOT destroy any documents. Do NOT discuss this with staff beyond what's necessary for patient care. Any of those actions can become separate criminal charges (obstruction, evidence tampering) even if the underlying prescribing was entirely legitimate.

Went through a DEA investigation 3 years ago. It was the worst 18 months of my life but I came out clean. Best advice: get a lawyer who specifically handles federal healthcare cases (not a general criminal attorney), follow their instructions to the letter, and keep practicing medicine. The investigation itself is not a conviction and most of your patients still need you.

If you haven't already, start documenting everything meticulously going forward. Every prescribing decision should have clear clinical justification in the chart. This protects you regardless of whether an investigation materializes.

Pharmacists are increasingly being named in federal healthcare fraud cases. Your documentation is your shield. Invest in a compliance program if you don't have one — it's far cheaper than a defense. And know that you DO have the right to refuse to fill prescriptions you believe are not for a legitimate medical purpose. That right is explicitly recognized in federal regulation.

You're not alone. The "corresponding responsibility" doctrine puts us in an impossible position. Document EVERYTHING — every conversation with a prescriber about a questionable script, every refusal, every verification call. If you have a compliance program, follow it religiously. If you don't have one, get one yesterday.

Typical ranges:

- Initial consultation: Free to $500. Many firms offer free phone consultations.
- Pre-investigation advisory/compliance review: $3,000–$10,000
- Responding to a subpoena: $5,000–$15,000
- Full investigation representation: $25,000–$75,000+
- Trial defense: $100,000–$500,000+

The earlier you engage, the less it costs. A $5,000 consultation that prevents a $50,000 investigation is the best money you'll ever spend. Most attorneys will work out payment plans for solo practitioners.

I paid about $35k total for my defense over 18 months. Was it painful? Yes. Would I do it again? In a heartbeat. The alternative — trying to handle it myself or hiring a cheap general attorney — would have cost me my license and my freedom.

The fact that you're thinking about this early is a good sign. Three things:\n\n1. Document meticulously. Every prescribing decision should have clear clinical justification. "Patient reports pain" is not enough. Physical exam findings, functional assessments, treatment plans.\n\n2. Get familiar with your state PDMP and check it for every controlled substance prescription. Make it a habit from day one.\n\n3. Find a mentor in your practice who models good prescribing practices. Observe how they handle difficult patients, how they document, how they say no when needed.\n\nYou don't need a defense attorney on retainer, but knowing who you'd call if needed is smart.

I'll add: make sure your malpractice insurance includes regulatory defense coverage (not just civil malpractice). Many policies exclude coverage for DEA/licensing board actions. Ask your carrier specifically. If they don't cover it, supplemental regulatory defense insurance is available and relatively inexpensive for new practitioners.

Running a ketamine clinic since 2021. The key is airtight protocols and documentation. We have:
- Written treatment protocols for every indication
- Informed consent that specifically addresses off-label use
- Pre-treatment screening including psychological evaluation
- Monitoring during and after infusion
- Follow-up documentation
- Clear exclusion criteria

The DEA has been more interested in compounding pharmacies than individual clinics so far, but that could change. Stay current with ASA and APA guidelines.

Ketamine clinics are an emerging enforcement target. The Schedule III classification gives you more flexibility than Schedule II, but the "legitimate medical purpose" standard still applies. The biggest risk areas I see: (1) inadequate patient screening, (2) lack of follow-up care, (3) advertising that makes medical claims beyond what's supported, (4) corporate practice of medicine violations if non-physicians have ownership stakes. Get a compliance review done proactively.

Key things for staff:

1. Never alter medical records after the fact for any reason
2. If a federal agent shows up, be polite but say "I need to contact our attorney before providing any information"
3. Don't discuss patient cases with anyone outside the practice
4. Follow your office's prescription verification protocol exactly — no shortcuts
5. Document any patient behavior that seems concerning (doctor shopping, lost prescriptions, etc.)

Annual compliance training for all staff is worth every penny.

Both. If you have your own DEA registration, you bear independent responsibility for your prescribing. If you're prescribing under a collaborating physician's DEA number, the supervising physician also has exposure. The DEA does not limit investigations to physicians — NPs, PAs, dentists, podiatrists, and veterinarians have all been targets of federal prescribing investigations.

The same standard applies: prescriptions must be issued for a legitimate medical purpose in the usual course of professional practice. Document your clinical reasoning for every controlled substance prescription.

I got my own DEA number specifically so I wouldn't be dragged into my collaborating physician's issues. Worth considering if you haven't already. It also makes your prescribing cleaner from a documentation standpoint.

Yes. Any DEA registrant who prescribes controlled substances is subject to the same federal standards. Dentists are increasingly scrutinized for opioid prescribing — the CDC's prescribing guidelines have been applied to dental practice. Veterinarians have seen a rise in diversion cases (drugs prescribed for animals being diverted to human use). The DEA does not distinguish by specialty — they look at prescribing patterns and whether they're consistent with legitimate medical practice.